GRIFOLS | GRF - Assets



GRIFOLS reported EUR19.77B in Assets for its fiscal quarter ending in June of 2025.


Assets Change Date
Alcon AG USD 31.39B 379M Jun/2025
Almirall EUR 2.31B 88.18M Jun/2025
Amadeus IT EUR 11.8B 400.3M Jun/2025
Amarin USD 655.68M 29.67M Mar/2025
argenx SE 7.18B 973.07M Jun/2025
AstraZeneca USD 112.42B 6.17B Jun/2025
Bayer EUR 105.24B 3.95B Jun/2025
Cie Automotive EUR 5.96B 129.12M Dec/2024
Demant DKK 32.64B 190M Jun/2025
Ence Energia y Celulosa EUR 1.74B 32.4M Jun/2025
Essilor EUR 61.93B 2.34B Jun/2025
Ferrovial EUR 26.56B 2.44B Jun/2025
Fresenius EUR 41.32B 1.89B Jun/2025
Fresenius Medical Care EUR 31.29B 1.44B Jun/2025
Galapagos EUR 3.82B 203.72M Jun/2025
Genmab DKK 6.46B 122M Jun/2025
GlaxoSmithKline GBP 59.26B 1.45B Jun/2025
GRIFOLS EUR 19.77B 1.21B Jun/2025
Hikma Pharmaceutical USD 5.13B 286M Dec/2024
Inditex EUR 34.78B 69M Apr/2025
Merck EUR 47.35B 2.02B Jun/2025
Novartis USD 104.4B 4.45B Jun/2025
Philips EUR 26.38B 788M Jun/2025
Roche Holding CHF 101.8B 6.02B Dec/2024
Sanofi 124.96B 6.93B Jun/2025
Smith & Nephew USD 10.69B 338M Jun/2025
UCB EUR 17.35B 1.72B Dec/2024
Viscofan EUR 1.44B 10.25M Jun/2025